Actively Recruiting
Evaluating Prefrontal Transcranial Photobiomodulation at 10 Hz and 40 Hz for Treatment-Resistant Major Depression with Somatic Symptoms
Led by Taipei Veterans General Hospital, Taiwan · Updated on 2026-04-30
40
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the clinical effects of moderate-dose transcranial photobiomodulation t-PBM at two different frequencies 10 Hz and 40 Hz in adults with treatment-resistant depression TRD. The study particularly focuses on the subtype of depression dominated by somatic symptoms. It also aims to explore changes in neurophysiological measures related to brain activity and their connection to symptom improvement. Participants will be randomly assigned to receive t-PBM treatment at either 10 Hz or 40 Hz. Each session involves applying near-infrared light to the prefrontal cortex for 20 minutes, twice weekly over four weeks, totaling eight sessions. The study seeks to compare the effects of these two stimulation frequencies and observe their impact on depressive and somatic symptoms. During the study, participants will undergo clinical assessments before and after treatment, including depression rating scales HDRS-17, MADRS, somatic symptom questionnaires, sleep quality evaluations, and overall functioning measures. Neurophysiological data will be collected using paired-pulse transcranial magnetic stimulation to assess brain excitability changes. The main outcome is the change in depression severity measured at baseline, after treatment, and at one-month follow-up. Safety and adherence will be monitored throughout the study, which is expected to last at least eight weeks per participant.
CONDITIONS
Brief Title
Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression
Research Team
J
Jia-Shyun Jeng
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here